Table 2.
Variable | Neonates (n = 116) |
Infants (n = 122) |
Children (n = 264) |
Adults (n = 93) |
---|---|---|---|---|
Ebstein’s repair | 31 (27.0%) | 10 (8.2%) | 79 (29.9%) | 43 (46.2%) |
Tricuspid valve repair | 8 (6.9%) | 8 (6.6%) | 36 (13.6%) | 7 (7.5%) |
Tricuspid valve replacement | 0 (0.0%) | 3 (2.5%) | 29 (11.0%) | 14 (15.1%) |
Tricuspid valve closure | 8 (6.9%) | 3 (2.5%) | 2 (0.8%) | 0 (0.0%) |
Systemic-to-pulmonary artery shunt | 32 (27.6%) | 10 (8.2%) | 1 (0.4%) | 0 (0.0%) |
Systemic-to-pulmonary artery shunt with tricuspid valve closure | 11 (9.5%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
Superior cavopulmonary connection | 1 (0.9%) | 64 (52.5%) | 16 (6.1%) | 0 (0.0%) |
Superior cavopulmonary connection with tricuspid valve closure | 0 (0.0%) | 2 (1.6%) | 1 (0.4%) | 0 (0.0%) |
Fontan | 0 (0.0%) | 0 (0.0%) | 39 (14.8%) | 5 (5.4%) |
Pacemaker implant or revision | 2 (1.7%) | 1 (0.8%) | 5 (1.9%) | 2 (2.2%) |
Atrial ablation or maze | 0 (0.0%) | 1 (0.8%) | 18 (6.8%) | 14 (15.1%) |
Atrial septal defect repair | 0 (0.0%) | 2 (1.6%) | 3 (1.1%) | 3 (3.2%) |
Heart transplant | 0 (0.0%) | 2 (1.6%) | 4 (1.5%) | 0 (0.0%) |